KONINKLIJKE PHILIPS NV (PHIA.AS) Fundamental Analysis & Valuation

AMS:PHIA • NL0000009538

Current stock price

23.13 EUR
-0.45 (-1.91%)
Last:

This PHIA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. PHIA.AS Profitability Analysis

1.1 Basic Checks

  • In the past year PHIA was profitable.
  • In the past year PHIA had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
  • PHIA had a positive operating cash flow in 4 of the past 5 years.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • The Return On Assets of PHIA (3.32%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 8.17%, PHIA is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • PHIA has a Return On Invested Capital (5.50%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for PHIA is significantly below the industry average of 10.21%.
  • The last Return On Invested Capital (5.50%) for PHIA is above the 3 year average (3.48%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.5%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • PHIA's Profit Margin of 5.02% is in line compared to the rest of the industry. PHIA outperforms 44.44% of its industry peers.
  • In the last couple of years the Profit Margin of PHIA has declined.
  • PHIA's Operating Margin of 7.98% is in line compared to the rest of the industry. PHIA outperforms 42.86% of its industry peers.
  • PHIA's Operating Margin has declined in the last couple of years.
  • PHIA has a Gross Margin of 45.18%. This is in the lower half of the industry: PHIA underperforms 76.19% of its industry peers.
  • PHIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PHIA.AS Health Analysis

2.1 Basic Checks

  • PHIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • PHIA has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PHIA has more shares outstanding
  • Compared to 1 year ago, PHIA has a worse debt to assets ratio.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • PHIA has an Altman-Z score of 1.98. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of PHIA (1.98) is comparable to the rest of the industry.
  • PHIA has a debt to FCF ratio of 16.37. This is a negative value and a sign of low solvency as PHIA would need 16.37 years to pay back of all of its debts.
  • PHIA has a Debt to FCF ratio of 16.37. This is comparable to the rest of the industry: PHIA outperforms 42.86% of its industry peers.
  • PHIA has a Debt/Equity ratio of 0.63. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
  • PHIA's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. PHIA is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z 1.98
ROIC/WACC0.88
WACC6.24%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • PHIA has a Current Ratio of 1.32. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.32, PHIA is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.94 indicates that PHIA may have some problems paying its short term obligations.
  • PHIA has a worse Quick ratio (0.94) than 60.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PHIA.AS Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.11% over the past year.
  • PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.62% yearly.
  • PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -1.03%.
  • Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.24% yearly.
  • Based on estimates for the next years, PHIA will show a small growth in Revenue. The Revenue will grow by 3.78% on average per year.
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue Next Year1.3%
Revenue Next 2Y2.87%
Revenue Next 3Y3.49%
Revenue Next 5Y3.78%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. PHIA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • PHIA is valuated correctly with a Price/Earnings ratio of 15.73.
  • Based on the Price/Earnings ratio, PHIA is valued cheaper than 85.71% of the companies in the same industry.
  • PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.21, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 15.12, the valuation of PHIA can be described as correct.
  • PHIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 66.67% of the companies in the same industry.
  • PHIA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.73
Fwd PE 15.12
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 74.60% of the companies in the same industry are more expensive than PHIA, based on the Enterprise Value to EBITDA ratio.
  • PHIA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 45.09
EV/EBITDA 10.98
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.9
PEG (5Y)N/A
EPS Next 2Y8.35%
EPS Next 3Y10.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHIA.AS Dividend Analysis

5.1 Amount

  • No dividends for PHIA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHIA.AS Fundamentals: All Metrics, Ratios and Statistics

KONINKLIJKE PHILIPS NV

AMS:PHIA (4/7/2026, 7:00:00 PM)

23.13

-0.45 (-1.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners47.46%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap22.27B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts74.67
Price Target29.57 (27.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.35
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)0.87%
PT rev (3m)7.21%
EPS NQ rev (1m)-0.95%
EPS NQ rev (3m)-33.29%
EPS NY rev (1m)0%
EPS NY rev (3m)0.18%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)5.94%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.39%
Valuation
Industry RankSector Rank
PE 15.73
Fwd PE 15.12
P/S 1.25
P/FCF 45.09
P/OCF 19.17
P/B 2.03
P/tB N/A
EV/EBITDA 10.98
EPS(TTM)1.47
EY6.36%
EPS(NY)1.53
Fwd EY6.61%
FCF(TTM)0.51
FCFY2.22%
OCF(TTM)1.21
OCFY5.22%
SpS18.52
BVpS11.38
TBVpS-0.92
PEG (NY)3.9
PEG (5Y)N/A
Graham Number19.4
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.5%
ROICexc 6.42%
ROICexgc 22.25%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
ROICexc(3y)3.99%
ROICexc(5y)N/A
ROICexgc(3y)13.73%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z 1.98
F-Score7
WACC6.24%
ROIC/WACC0.88
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.3%
Revenue Next 2Y2.87%
Revenue Next 3Y3.49%
Revenue Next 5Y3.78%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.67%
EBIT Next 3Y26.47%
EBIT Next 5Y17.86%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NV / PHIA.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


What is the valuation status for PHIA stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


What is the profitability of PHIA stock?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 3 / 10.


What is the financial health of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 2 / 10.


Can you provide the expected EPS growth for PHIA stock?

The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NV (PHIA.AS) is expected to grow by 4.04% in the next year.